Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999629 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
Coadministration of low-dose P reduced the incidence of peripheral edema, grade 3 nonhematological toxicity, and the risk of being admitted owing to febrile neutropenia during treatment with D. Adjusted survival analysis did not indicate that P affected prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Per M.D., Inge Marie M.D., Ph.D., Henriette M.D., Ph.D., Gedske M.D., D.M.Sc., Lisa M.D., D.M.Sc.,